A1B and BB blood group genotypes are risk factors for pulmonary embolism
- PMID: 34081189
- DOI: 10.1007/s00508-021-01882-3
A1B and BB blood group genotypes are risk factors for pulmonary embolism
Abstract
Background: Pulmonary embolism (PE) is a potentially life-threatening condition that mainly affects the people of advanced age. While certain blood group phenotypes (non‑O blood group) are known risk factors for the development of venous thromboembolism (VTE), there is no research which investigated the association of blood group genotypes with severity of PE. The aim of this study was to investigate the frequency of ABO blood group genotypes among the population of patients with PE and to investigate the correlation of the pulmonary embolism severity index (PESI) score to specific ABO blood group genotypes.
Material and methods: In this cross-sectional study 74 patients with PE diagnosed using CT pulmonary angiography were included and 303 blood donors without VTE or congenital thrombophilia participated as a control group. After isolation of genomic DNA ABO blood group genotype was determined using the polymerase chain reaction sequence-specific amplification (PCR-SSP) method.
Results: We observed a significantly higher frequency of A1B and BB genotypes in patients with PE compared to healthy individuals (A1B 14.9% vs. 4.3%, P < 0.001; BB 5.4% vs. 0.7%, P = 0.004), while the O1O1 genotype was significantly less frequent in patients (24.3% vs. 37.3%, P = 0.036). Analyzing the severity of the clinical presentation according to the PESI score, we did not find a correlation between the severity of the clinical presentation and a certain blood type genotype.
Conclusion: Patients with A1B and BB blood type genotype were at increased risk for developing pulmonary embolism, while patients with O1O1 genotype had a significantly lower risk of developing PE.
Keywords: ABO blood group genotypes; Life-threatening; Pulmonary embolism; Pulmonary embolism severity index.
© 2021. Springer-Verlag GmbH Austria, part of Springer Nature.
References
-
- ESC. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(543):603. https://doi.org/10.1093/eurheartj/ehz405 . - DOI
-
- Pun VC, Hart JE, Kabrhel C, Camargo CA Jr, Baccarelli AA, Laden F. Prospective study of ambient particulate matter exposure and risk of pulmonary embolism in the nurses’ health study cohort. Environ Health Perspect. 2015;123(12):1265–70. https://doi.org/10.1289/ehp.1408927 . - DOI - PubMed - PMC
-
- Dentali F, Riva N, Turato S, et al. Pulmonary embolism severity index accurately predicts long-term mortality rate in patients hospitalized for acute pulmonary embolism. J Thromb Haemost. 2013;11(12):2103–10. https://doi.org/10.1111/jth.12420 . - DOI - PubMed
-
- Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383–9. https://doi.org/10.1001/archinternmed.2010.199 . - DOI - PubMed
-
- Erythropoulou-Kaltsidou A, Alkagiet S, Tziomalos K. New guidelines for the diagnosis and management of pulmonary embolism: Key changes. WJC. 2020;12(5):161–6. https://doi.org/10.4330/wjc.v12.i5.161 . - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
